HCPCS Level IIdrugActive
J7170
Inj., emicizumab-kxwh 0.5 mg
BETOS: O1E
Effective: 2019-01-01
Referenced in 5 policies
Description
Injection, emicizumab-kxwh, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Hemlibra
Manufacturer
Genentech, Inc.
HCPCS Dosage
0.5 MG
Billing Units
60.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.